KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Boston Scientific (BSX) over the last 6 years, with Q4 2025 value amounting to $285.0 million.

  • Boston Scientific's Change in Accured Expenses fell 2597.4% to $285.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $296.0 million, marking a year-over-year increase of 2181.07%. This contributed to the annual value of $296.0 million for FY2025, which is 2181.07% up from last year.
  • Latest data reveals that Boston Scientific reported Change in Accured Expenses of $285.0 million as of Q4 2025, which was down 2597.4% from $165.0 million recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Change in Accured Expenses peaked at $385.0 million during Q4 2024, and registered a low of -$450.0 million during Q1 2024.
  • Moreover, its 5-year median value for Change in Accured Expenses was $47.0 million (2023), whereas its average is $40.5 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 535714.29% in 2022, then skyrocketed by 157391.3% in 2024.
  • Over the past 5 years, Boston Scientific's Change in Accured Expenses (Quarter) stood at $133.0 million in 2021, then skyrocketed by 151.88% to $335.0 million in 2022, then tumbled by 93.13% to $23.0 million in 2023, then soared by 1573.91% to $385.0 million in 2024, then decreased by 25.97% to $285.0 million in 2025.
  • Its Change in Accured Expenses stands at $285.0 million for Q4 2025, versus $165.0 million for Q3 2025 and $231.0 million for Q2 2025.